Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes. 2017

Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
Department of Endocrinology, Diabetes and Nutrition, Charité-University Medicine Berlin, Berlin, Germany.

Insulin-like growth factor binding protein-2 (IGFBP-2) is the predominant IGF binding protein produced during adipogenesis and is known to increase the insulin-stimulated glucose uptake (GU) in myotubes. We investigated the IGFBP-2-induced changes in basal and insulin-stimulated GU in adipocytes and the underlying mechanisms. We further determined the role of insulin and IGF-1 receptors in mediating the IGFBP-2 and the impact of IGFBP-2 on the IGF-1-induced GU. Fully differentiated 3T3-L1 adipocytes were treated with IGFBP-2 in the presence and absence of insulin and IGF-1. Insulin, IGF-1, and IGFBP-2 induced a dose-dependent increase in GU. IGFBP-2 increased the insulin-induced GU after long-term incubation. The IGFBP-2-induced impact on GU was neither affected by insulin or IGF-1 receptor blockage nor by insulin receptor knockdown. IGFBP-2 significantly increased the phosphorylation of PI3K, Akt, AMPK, TBC1D1, and PKCζ/λ and induced GLUT-4 translocation. Moreover, inhibition of PI3K and AMPK significantly reduced IGFBP-2-stimulated GU. In conclusion, IGFBP-2 stimulates GU in 3T3-L1 adipocytes through activation of PI3K/Akt, AMPK/TBC1D1, and PI3K/PKCζ/λ/GLUT-4 signaling. The stimulatory effect of IGFBP-2 on GU is independent of its binding to IGF-1 and is possibly not mediated through the insulin or IGF-1 receptor. This study highlights the potential role of IGFBP-2 in glucose metabolism.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D017667 Adipocytes Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. Fat Cells,Lipocytes,Adipocyte,Cell, Fat,Cells, Fat,Fat Cell,Lipocyte
D051275 Glucose Transporter Type 4 A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake. GLUT-4 Protein,GLUT4 Protein,Insulin-Responsive Glucose Transporter,SLC2A4 Protein,Solute Carrier Family 2, Facilitated Glucose Transporter, Member 4 Protein,GLUT 4 Protein,Glucose Transporter, Insulin-Responsive,Insulin Responsive Glucose Transporter
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018971 Insulin-Like Growth Factor Binding Protein 2 One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level. IGF-Binding Protein 2,IGFBP-2,IGF Binding Protein 2,IGFBP 2,Insulin Like Growth Factor Binding Protein 2
D041721 3T3-L1 Cells A continuous cell line that is a substrain of SWISS 3T3 CELLS developed though clonal isolation. The mouse fibroblast cells undergo an adipose-like conversion as they move to a confluent and contact-inhibited state. 3T3-L1,3T3 L1 Cells,3T3-L1 Cell,Cell, 3T3-L1,Cells, 3T3-L1

Related Publications

Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
December 1990, Biochemical Society transactions,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
February 2009, Biochemical and biophysical research communications,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
September 2006, Biochemical and biophysical research communications,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
November 1990, Biochemical and biophysical research communications,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
January 1993, The Journal of biological chemistry,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
June 1996, Brain research. Molecular brain research,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
January 2001, Endocrinology,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
June 2009, Archives of biochemistry and biophysics,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
December 1997, Journal of molecular endocrinology,
Biruhalem Assefa, and Ayman M Mahmoud, and Andreas F H Pfeiffer, and Andreas L Birkenfeld, and Joachim Spranger, and Ayman M Arafat
September 2008, The Journal of endocrinology,
Copied contents to your clipboard!